We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Pharmacovigilance – Products

Dr Alastair Smith, Chief Executive Officer of Avacta Group.
Product News

Avacta Announces Successful Completion of Fourth Dose Escalation in Phase 1 Clinical Study

Avacta Group plc announces that AVA6000 continues to show a very favorable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase 1 clinical trial.
Thermo Scientific Gallery Enzyme Master Enzyme Analyzer
Product News

Thermo Fisher Scientific’s Advanced Analytical Instruments Receive R&D 100 Awards

Thermo Fisher Scientific Inc. received R&D 100 Awards from R&D World Magazine for two of its most recently launched analytical instruments.
Rack of tubes containing blood in a laboratory.
Product News

Personalis and UCSF To Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer

Personalis has announced a collaboration with UC San Francisco that will deploy a personalized liquid biopsy-based research use only assay for a study of patients with colorectal cancer.
App Note / Case Study

Comprehensive Characterization of O-Linked Glycosylation in Etanercept by Electron Activated Dissociation

Glycosylation is a common post-translational modification (PTM) that plays a critical role in antibody effector functions. Comprehensive characterization of N- and O-linked glycosylation in protein therapeutics is essential for ensuring drug safety and efficacy.
Product News

PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select To Automate Clinically Superior Tuberculosis Detection

PerkinElmer’s Oxford Immunotec has announced the U.S. Food and Drug Administration has approved the use of the T-Cell Select™ reagent kit for the automation of its T-SPOT®.TB test workflow for in vitro diagnostic use by certified laboratories.
Product News

Molecular Devices and HeartBeat.bio Announce Collaboration To Automate and Scale Cardiac Organoids

Molecular Devices, LLC. and HeartBeat.bio AG, a biotech company developing cardiac organoids for drug discovery, have entered into a co-development agreement.
Product News

SonALAsense Forges Ahead With First Patient Dosing for Devastating Childhood Brain Cancer

Multisite study will test sonodynamic therapy in pediatric patients with diffuse intrinsic pontine glioma (DIPG).
Product News

Voltron Therapeutics, Inc. Announces Definitive Proof of Concept Data for its Lead Oncology Candidate

Voltron Therapeutics, Inc. has announced that data from the previously announced Study ‘098 demonstrated clear Proof-of Concept for VTX-067 in the treatment of HPV-related cancers.
Product News

Epilepsy Patients Set To Benefit From Non-Invasive, Real-Time Molecular Breath Analysis

Deep Breath Intelligence is pleased to announce the launch of a simple breath test that can provide reliable estimates of circulating concentrations of the antiseizure medication valproic acid to aid patient management.
Product News

VectorBuilder To Invest $30 Million To Build the World’s First "AAV Superbank"

VectorBuilder Inc. has announced its plan to invest $30 million to build an "AAV Superbank" for the research and drug discovery community.